Advanced International Journal for Research
E-ISSN: 3048-7641
•
Impact Factor: 9.11
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with AIJFR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 1
January-February 2026
Indexing Partners
Prognostic factors and survival outcomes in patients with hepatocellular carcinoma: a retrospective monocentric study
| Author(s) | Prof. Sanaa Berrag, Prof. Lamiae Alaoui, Prof. Fouad Nejjari, Prof. Tarik Adioui, Prof. Mouna Tamzaourte |
|---|---|
| Country | Morocco |
| Abstract | Abstract Background Hepatocellular carcinoma (HCC) is the most common primary liver cancer and remains a leading cause of cancer-related mortality worldwide. Prognosis is largely determined by tumor stage at diagnosis and the severity of underlying liver disease. Real-world data are essential to better characterize disease presentation, management, and prognostic factors. Methods We conducted a descriptive, analytical, retrospective, single-center study including patients diagnosed with HCC between January 2020 and January 2025. Diagnosis was established according to European Association for the Study of the Liver imaging criteria or histology when indicated. Demographic, clinical, radiological, and therapeutic data were collected. Overall survival was analyzed using the Kaplan–Meier method. Prognostic factors associated with survival were assessed using univariate and multivariate analyses. Results Seventy-four patients were included, with a mean age of 69.5 years and a marked male predominance. Cirrhosis was present in 97.3% of cases, mainly related to hepatitis C virus infection. Most patients were diagnosed at intermediate or advanced stages according to the Barcelona Clinic Liver Cancer classification. Treatment was predominantly palliative. Median overall survival was 10 months. In multivariate analysis, Child–Pugh C status, portal vein invasion, and the presence of extrahepatic metastases were independently associated with reduced survival. Conclusion Hepatocellular carcinoma was frequently diagnosed at an advanced stage and associated with poor survival. Liver function and tumor-related factors were the main determinants of prognosis. These findings highlight the need for improved surveillance strategies to enable earlier diagnosis and increase access to curative treatment options |
| Keywords | Hepatocellular carcinoma; Liver cirrhosis; Prognostic factors; Barcelona Clinic Liver Cancer; Child–Pugh score; Overall survival |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 1, January-February 2026 |
| Published On | 2026-02-01 |
Share this

E-ISSN 3048-7641
CrossRef DOI is assigned to each research paper published in our journal.
AIJFR DOI prefix is
10.63363/aijfr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.